BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Clinical Outcome
9 results:

  • 1. Association of cxcr4 Expression and clinical outcome in Different Subsets of De Novo Acute Myeloid leukemia Patients.
    Rady AS; Badawy RH; Gamal BME; Darwish AD; Aziz RSA; Gammal ME; Goweda RA
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162869
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation.
    Bartholdy BA; Wang X; Yan XJ; Pascual M; Fan M; Barrientos J; Allen SL; Martinez-Climent JA; Rai KR; Chiorazzi N; Scharff MD; Roa S
    Blood Adv; 2020 Mar; 4(5):893-905. PubMed ID: 32150608
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CD97 expression is associated with poor overall survival in acute myeloid leukemia.
    Vaikari VP; Yang J; Wu S; Alachkar H
    Exp Hematol; 2019 Jul; 75():64-73.e4. PubMed ID: 31260716
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets.
    Maiga A; Lemieux S; Pabst C; Lavallée VP; Bouvier M; Sauvageau G; Hébert J
    Blood Cancer J; 2016 Jun; 6(6):e431. PubMed ID: 27258612
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response.
    Bologna C; Buonincontri R; Serra S; Vaisitti T; Audrito V; Brusa D; Pagnani A; Coscia M; D'Arena G; Mereu E; Piva R; Furman RR; Rossi D; Gaidano G; Terhorst C; Deaglio S
    J Clin Invest; 2016 Jan; 126(1):181-94. PubMed ID: 26619119
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic leukemia.
    Patrussi L; Capitani N; Martini V; Pizzi M; Trimarco V; Frezzato F; Marino F; Semenzato G; Trentin L; Baldari CT
    Cancer Res; 2015 Oct; 75(19):4153-63. PubMed ID: 26282174
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Defective NK Cells in Acute Myeloid leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion.
    Khaznadar Z; Boissel N; Agaugué S; Henry G; Cheok M; Vignon M; Geromin D; Cayuela JM; Castaigne S; Pautas C; Raffoux E; Lachuer J; Sigaux F; Preudhomme C; Dombret H; Dulphy N; Toubert A
    J Immunol; 2015 Sep; 195(6):2580-90. PubMed ID: 26246143
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
    Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
    Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia.
    Calissano C; Damle RN; Hayes G; Murphy EJ; Hellerstein MK; Moreno C; Sison C; Kaufman MS; Kolitz JE; Allen SL; Rai KR; Chiorazzi N
    Blood; 2009 Nov; 114(23):4832-42. PubMed ID: 19789386
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.